Brain Scans Show How Ketamine Lifts Treatment-Resistant Depression
A March 2026 study published in Molecular Psychiatry uses PET brain imaging to offer a clearer look at how ketamine may rapidly improve symptoms in treatment-resistant depression.
A March 2026 study published in Molecular Psychiatry uses PET brain imaging to offer a clearer look at how ketamine may rapidly improve symptoms in treatment-resistant depression.
New (May 2026) ASKP3 ketamine guidelines explain IV ketamine induction, maintenance, dosing, and safety for effective depression treatment.
A study published in JAMA in March of 2026 says psychedelics are no better than antidepressants for depression. Here’s why the headline misses key context on side effects, duration, and healing.
Ketamine dosing explained: IV, IM, intranasal, and oral routes compared: bioavailability, clinical research, and how dosing decisions are made.